Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003. (Q45868417)

17 December 2017

title

Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003. (English)

1 reference

17 December 2017

6

Eithan Galun

0 references

author name string

Michal Abraham

1

1 reference

17 December 2017

Katia Biyder

2

1 reference

17 December 2017

Michal Begin

3

1 reference

17 December 2017

Hanna Wald

4

1 reference

17 December 2017

Ido D Weiss

5

1 reference

17 December 2017

Arnon Nagler

7

1 reference

17 December 2017

Amnon Peled

8

1 reference

17 December 2017

publication date

24 May 2007

1 reference

17 December 2017

published in

Stem Cells

1 reference

17 December 2017

volume

25

1 reference

17 December 2017

issue

9

1 reference

17 December 2017

page(s)

2158-2166

1 reference

17 December 2017

BIOLOGY OF HEMATOPOIETIC STEM CELLS AND PROGENITORS: Implications for Clinical Application

cites work

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

Physiological migration of hematopoietic stem and progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

HIV chemokine receptor inhibitors as novel anti-HIV drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

Markers of mouse macrophage development detected by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

Pegfilgrastim for chemotherapy-induced neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

Rapid mobilization of CD34 cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

Two orthogonal approaches to overcome multi-drug resistant HIV-1s: development of protease inhibitors and entry inhibitors based on CXCR4 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

G protein-coupled receptors in natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1634/STEMCELLS.2007-0161

10.1634/STEMCELLS.2007-0161

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017